BeyondSpring Inc. (BYSI)
About BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2017
- $0
- Net income
- -$1.0M
- Total assets
- $25.9M
- Market cap
- $70.3M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating income
- -$8.9M
- Income tax
- $90.0K
- Net income
- -$14.2M
- EPS (basic)
- $-0.02
Balance sheet
- Total assets
- $25.9M
- Current assets
- $20.9M
- Total liabilities
- $49.9M
- Current liabilities
- $13.6M
- Shareholders’ equity
- -$24.0M
Cash flow
- Operating cash flow
- -$19.8M
- Investing cash flow
- $10.8M
- Financing cash flow
- $5.0M
- Net cash flow
- -$4.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $70.3M
- Shares outstanding
- 62.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 9, 2017
BeyondSpring Inc. (BYSI) Stock Price
- Reported a net loss of $1.0M in FY2017.
- Trading 65% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BeyondSpring Inc..
Write a review
News about BeyondSpring Inc.
News & sentiment via Polygon.io
BeyondSpring Inc.: frequently asked questions
Is BeyondSpring Inc. an American company?
BeyondSpring Inc. is a US-based company headquartered in Florham Park, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is BeyondSpring Inc. headquartered?
BeyondSpring Inc. is headquartered in Florham Park, New Jersey, United States.
Is BeyondSpring Inc. publicly traded?
Yes — BeyondSpring Inc. is a publicly traded company. Its stock trades under the ticker symbol BYSI on the NASDAQ.
What does BeyondSpring Inc. do?
BeyondSpring Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
